Company

Board of Management

The  members of the Board of Management jointly share responsibility for the company’s management. The management tasks of the Board of Management include strategic planning, allocation of resources, accounting and financial reporting, risk management and control for the group.

Peter Janssen

Chairman of the Board of Management

Peter Janssen is CEO and Chairman of the Management Board since January, 2024 – he has been member of the Management Board since 2022. He was previously leading Commercial and Industrial Operations as COO. Before joining Biotest, he was Executive VP of Prothya Netherlands and CEO of Prothya Belgium. Mr. Janssen also worked 14 years for Pfizer and 5 years for its animal health spin-off Zoetis where he performed various transformational, strategic and global operational roles with increasing responsibilities.
Peter started his career as an assistant Professor at the University of Leuven in Belgium, was a reserve officer at the Belgian Air Force and worked in the semiconductor division of Air Products in Pennsylvania, US. He holds a Master of Science degree in Electro-Mechanical Engineering, a Master degree in Applied Economics and Business Degree from INSEAD, France. Peter Janssen was born in 1966.

Ainhoa Mendizabal Zubiaga

Chief Financial Officer

Ainhoa Mendizabal has been a member of the Board of Management of Biotest AG since February 2023. As Chief Financial Officer, Ms Mendizabal is responsible within the Biotest Group for the areas of finance including the treasury and tax department, controlling, investor relations and insurance. Previously, Ms Mendizabal held various executive and managerial positions in the Grifols Group in Germany and in Europe. Ms Mendizabal also worked for several years in an international consulting firm in the area of CFO Services and Enterprise Applications. From there, she moved to Talecris Biotherapeutics GmbH before Talecris was acquired by Grifols S.A.. Ainhoa Mendizabal holds a dual Master of Business Administration in Germany and Spain. Ms Mendizabal was born in 1972.

Dr. Jörg Schüttrumpf

Chief Scientific Officer

In January 2022 Dr. Schüttrumpf has been appointed to the Board of Management at Biotest AG. Since September 2023 Dr. Schüttrumpf has also been Chief Scientific Innovation Officer (CSIO) at Grifols S.A. In this role, he drives the strategic focus on growth as a provider of innovative medicines also for the company group. Since 2015 he was responsible for the Research & Development Division, and since 2012 for Global Research at Biotest AG. Before, Dr. Schüttrumpf worked at different academic and non-government organizations in Germany and the US, among those the German Red Cross Blood Donor Service, the Goethe University Frankfurt, the University Hospital of Essen, The Children’s Hospital of Philadelphia, and the University of Pennsylvania. Dr. Schüttrumpf has studied medicine, is specialized in transfusion medicine and haemostaseology, and has a Master of Business Administration from IMD Business School. Dr. Jörg Schüttrumpf was born in 1974.